AGN News and Press, Allergan plc From 03/06/20

VANCOUVER, British Columbia, March 06, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company is pleased to announce that it is expl...

There are a lot of promising stocks out there for investors to choose from. However, if you're looking for companies with the most growth potential, the world of small-cap stocks is one of the best places to look. In particular, biotech stocks are very well known for having tremendous upside ...

The Food and Drug Administration (FDA) has approved Biohaven Pharmaceutical 's (NYSE: BHVN) Nurtec ODT as an acute migraine treatment. Shares of the company were up 7.8% at 7:08 p.m. EST in after-hours trading after falling 8.5% during the regular session. The drug melts in your mouth, liter...

AbbVie (NYSE: ABBV) was officially launched on Jan. 2, 2013 as a spinoff from Abbott Laboratories (NYSE: ABT) . That was the first day the company traded on the New York Stock Exchange. The move was made so that Abbott could focus on its business of manufacturing medical devices and equip...

A deal isn't done until the ink dries on the paper. And for AbbVie 's (NYSE: ABBV) pending acquisition of Allergan (NYSE: AGN) , the ink hasn't dried yet. AbbVie first announced plans to buy Allergan in June 2019. CEO Rick Gonzalez stated in the company's Q4 conference call earlier this...

The U.S. stock markets took a sizable step backwards yesterday, presumably on the emerging COVID-19 threat. A more careful look, however, suggests that the market was basically due for a correction. After all, most major indices were bumping up against their all-time highs, and valuations across...

DUBLIN , Feb. 25, 2020 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company with a more than 70-year heritage in ophthalmology, will present new data from investigational Bimatoprost Sustained-Release (SR) at the Annual Meeting of the American Glaucoma S...

BioCryst Pharmaceuticals Goes Ahead with FDA Marketing Application BioCryst Pharmaceuticals ( BCRX ) reported that the FDA has accepted its marketing application for review. The application pertains to its drug candidate Berotralstat designed to prevent hereditary angioedema attacks. The ...

This article is part of a series that provides an ongoing analysis of the changes made to David Tepper’s 13F portfolio on a quarterly basis. It is based on Appaloosa Management’s regulatory 13F Form filed on 02/14/2020. Please visit our Tracking David Tepper’s Appaloosa...

This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 02/14/2020. Please visit our Tracking John Paulson's Paulson & Company Portfolio serie...